Cargando…
Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 and has quickly become a worldwide pandemic. In response, many diagnostic manufacturers have developed molecular assays for SARS-CoV-2 under the Food and Drug Administration (FDA) Emergency Use Authori...
Autores principales: | Smith, Elizabeth, Zhen, Wei, Manji, Ryhana, Schron, Deborah, Duong, Scott, Berry, Gregory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448672/ https://www.ncbi.nlm.nih.gov/pubmed/32571894 http://dx.doi.org/10.1128/JCM.01134-20 |
Ejemplares similares
-
Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2
por: Zhen, Wei, et al.
Publicado: (2020) -
Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens
por: Zhen, Wei, et al.
Publicado: (2020) -
Multicenter Evaluation of the BioFire Respiratory Panel 2.1 (RP2.1) for Detection of SARS-CoV-2 in Nasopharyngeal Swab Samples
por: Berry, Gregory J., et al.
Publicado: (2022) -
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test
por: Mostafa, Heba H., et al.
Publicado: (2021) -
Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type()
por: Lephart, Paul R., et al.
Publicado: (2021)